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Abstract		Background:	There	is	limited	information	on	the	volume	of	influenza-associated	mortality	in	Russia.		Methods:	Using	previously	developed	methodology	(Goldstein	et	al.,	Epidemiology	2012),	we	regressed	the	monthly	rates	of	mortality	for	respiratory	causes,	circulatory	causes,	and	for	certain	infectious	and	parasitic	diseases	(available	from	the	Russian	Federal	State	Statistics	Service	(Rosstat))	linearly	against	the	monthly	proxies	for	the	incidence	of	influenza	A/H3N2,	A/H1N1	and	B	(obtained	using	data	from	the	Smorodintsev	Research	Institute	of	Influenza	(RII)	on	levels	of	ILI/ARI	consultations	and	the	percent	of	respiratory	specimens	testing	positive	for	influenza	A/H3N2,	A/H1N1	and	B),	adjusting	for	the	baseline	rates	of	mortality	not	associated	with	influenza	circulation	and	temporal	trends.		Results:	For	the	2010/11	through	the	2014/15	seasons,	influenza	circulation	was	associated	with	an	average	annual	11106	(95%	CI	(4321,17892))	deaths	for	circulatory	causes,	4552	(3744,5360)	deaths	for	respiratory	causes,	and	343	(63,624)	deaths	for	certain	infectious	and	parasitic	diseases,	with	influenza	A/H3N2	being	responsible	for	the	majority	of	influenza-associated	respiratory	deaths	and	influenza	B	making	a	substantial	contribution	to	influenza-associated	mortality	for	circulatory	causes.	
	Conclusions:	Influenza	circulation	is	associated	with	a	substantial	mortality	burden	in	Russia,	particularly	for	circulatory	deaths.	Those	results	support	the	potential	utility	of	influenza	vaccination	(with	the	role	played	by	influenza	B	in	circulatory	mortality	pointing	to	the	benefit	of	quadrivalent	influenza	vaccines),	as	well	as	of	administration	of	antiviral	drugs	for	high-risk	individuals	during	periods	of	active	influenza	circulation.			
Introduction	
	Annual	epidemics	associated	with	the	circulation	of	influenza	A/H3N2,	A/H1N1	and	B	take	place	in	Russia	[1].	Such	epidemics	are	known	to	result	in	a	substantial	toll	of	mortality	in	other	countries	in	the	Northern	Hemisphere,	e.g.	[2-7],	including	mortality	for	circulatory	causes	[2,3],	with	influenza	additionally	known	to	be	associated	with	a	variety	of	cardiovascular	manifestations	[8].	At	the	same	time,	there	is	limited	information	on	the	national	burden	of	influenza-associated	mortality	in	Russia.	Estimates	of	the	rates	of	influenza-associated	mortality	in	Russia	for	select	influenza	seasons	exist	on	a	regional	level,	particularly	for	the	city	of	St.	Petersburg	[9].	At	the	same	time,	the	rates	of	influenza-associated	mortality	vary	both	spatially,	as	well	as	year-to-year.	For	example,	while	influenza	A,	particularly	influenza	A/H3N2	is	known	to	be	a	major	source	of	excess	mortality	[10],	the	2017/18	season	in	Europe	saw	high	levels	of	excess	mortality	associated	with	the	circulation	of	influenza	B/Yamagata	strains	[11],	with	those	strains	not	being	included	in	trivalent	influenza	vaccines.	Additionally,	the	overall	rates	of	death	for	circulatory	diseases	in	Russia	are	high	[12],	and	there	is	evidence	that	influenza	B	plays	an	important	role	in	influenza-associated	circulatory	mortality,	e.g.	[13],	as	well	as	Table	3	in	[2]	(comparison	of	regression	coefficients	for	circulatory	vs.	respiratory	mortality).	It	is	important	therefor	to	consider	national	data	from	a	number	of	influenza	seasons	to	address	the	uncertainty	regarding	the	national	burden	of	mortality	associated	with	the	circulation	of	the	major	influenza	(sub)types	(A/H3N2,	A/H1N1	and	B)	in	Russia	for	different	causes	of	death,	including	respiratory	and	circulatory	diseases.	Such	estimates	are	important	for	planning	
mitigation	efforts,	including	vaccination	and	administration	of	antiviral	medications	to	certain	population	groups	during	active	circulation	of	the	different	influenza	(sub)types.		In	our	earlier	work	[2,3,14],	we	introduced	a	new	method	for	estimating	the	burden	of	severe	outcomes	associated	with	influenza	and	the	respiratory	syncytial	virus	(RSV),	designed	to	address	several	limitations	of	some	of	the	previously	employed	inference	models.	An	important	feature	of	that	approach	is	the	use	of	RSV	and	influenza	A/H3N2,	A/H1N1,	and	B	incidence	proxies	that	are	expected	to	be	linearly	related	to	the	population	incidence	of	those	viruses;	such	proxies	for	influenza	(sub)types	combine	data	on	medical	consultations	for	influenza-like	illness	(ILI)	with	data	on	the	testing	of	respiratory	specimens	from	symptomatic	individuals	[2,3,7].	We’ve	applied	those	incidence	proxies	to	estimate	the	rates	of	influenza-associated	mortality	stratified	by	age/cause	of	death	in	the	US	[2,3],	with	the	corresponding	method	being	later	adopted	for	the	estimation	of	influenza-associated	mortality	in	other	countries	as	well,	e.g.	[5-7].	In	this	paper,	we	derive	the	analogous	proxies	for	the	weekly/monthly	incidence	of	influenza	A/H3N2,	A/H1N1,	and	B	in	Russia	based	on	the	surveillance	data	from	the	Smorodintsev	Research	Institute	of	Influenza	(RII)	[15].	We	then	apply	the	inference	model	from	[2,3,14]	to	relate	those	incidence	proxies	to	the	monthly	data	from	the	Russian	Federal	State	Statistics	Service	(Rosstat)	[16]	on	the	rates	of	death	for	respiratory	causes,	circulatory	causes,	and	deaths	for	certain	infectious	and	parasitic	diseases	to	estimate	the	corresponding	mortality	rates	associated	with	the	circulation	of	the	major	influenza	(sub)types	during	the	2010/11	through	the	2014/15	influenza	seasons	in	Russia.			
Methods		
Data	Monthly	data	on	mortality	for	certain	major	causes	of	death	in	Russia	are	obtained	from	[16].	We’ll	concentrate	on	respiratory	deaths,	circulatory	deaths,	and	deaths	for	certain	infectious	and	parasitic	diseases	(with	about	60%	of	the	latter	deaths	in	2018	being	HIV-
related,	and	another	25%	being	TB-related,	[12]).	Influenza	is	known	to	be	associated	with	mortality	for	other	causes	as	well,	including	neoplasms	and	metabolic	diseases	[2,9];	however	finer	(e.g.	weekly)	mortality	data	are	needed	to	ascertain	the	signals	from	influenza	circulation	in	the	corresponding	time	series.			Weekly	data	on	the	rates	of	ILI/ARI	consultation	per	10,000	individuals	in	Russia	are	available	from	[15]	(with	some	of	the	data	during	the	study	period	missing	in	[15]	and	can	be	found	in	the	Russian	language	version	of	the	Smorodintsev	Institute	Surveillance	database	[17]).	Refs.	[15,17]	also	contain	the	weekly	data	on	the	percent	of	respiratory	specimens	from	symptomatic	individuals	that	were	RT-PCR	positive	for	influenza	A/H1N1,	A/H3N2	and	influenza	B.			
Inference	method	Only	a	fraction	of	individuals	presenting	with	ILI/ARI	symptoms	are	infected	with	influenza.	We	multiplied	the	weekly	rates	of	ILI/ARI	consultation	per	10,000	individuals	[15,17]	by	the	weekly	percentages	of	respiratory	specimens	from	symptomatic	individuals	that	were	RT-PCR	positive	for	each	of	influenza	A/H1N1,	A/H3N2	and	B	[15,17]	to	estimate	the	weekly	incidence	proxies	for	each	of	the	corresponding	influenza	(sub)types:			
Weekly	influenza	(sub)type	incidence	proxy	=																																				(1)	
=	Rate	of	consultations	for	ILI/ARI	*	%	All	respiratory	specimens	that	were	positive	for	the	
(sub)type		As	noted	in	[2],	those	proxies	are	expected	to	be	proportional	to	the	weekly	population	incidence	for	the	each	of	the	major	influenza	(sub)types	(hence	the	name	“proxy”).	Monthly	incidence	proxies	for	influenza	A/H1N1,	A/H3N2	and	B	were	obtained	as	the	weighted	average	of	the	weekly	incidence	proxies	for	those	weeks	that	overlapped	with	a	given	month;	specifically,	for	each	influenza	(sub)type	and	month,	the	incidence	proxy	for	each	week	was	multiplied	by	the	number	of	days	in	that	week	that	were	part	of	the	corresponding	month	(e.g.	7	if	the	week	was	entirely	within	that	month),	then	the	
results	were	summed	over	the	different	weeks	and	divided	by	the	number	of	days	in	the	corresponding	month.	Figure	1	plots	the	monthly	incidence	proxies	(which	are	estimated	as	daily	averages	over	a	month)	for	influenza	A/H1N1,	A/H3N2	and	B	in	Russia	between	09/2010	and	12/2015	(64	months),	with	that	time	period	chosen	for	inference	purposes	as	we	have	information	on	both	influenza	surveillance	and	monthly	mortality	during	that	period	[15-17].	Figure	1	suggests	a	very	large	incidence	proxy	for	influenza	A/H1N1	during	the	2010/11	season.	This	may	have	to	do	with	the	fact	that	the	age	distribution	of	cases	for	the	2010/11	A/H1N1	epidemic	was	different	compared	to	the	subsequent	A/H1N1	epidemics,	and	the	ratio	between	the	A/H1N1	incidence	proxy	and	the	rates	of	A/H1N1-associated	mortality	is	potentially	different	for	the	2010/11	season	compared	to	later	seasons.	Correspondingly,	we	split	the	A/H1N1	incidence	proxy	into	two	(𝐴/𝐻1𝑁1!	for	the	2010/11	season,	and	𝐴/𝐻1𝑁1!	for	the	later	seasons).		Earlier	work	(e.g.	[2])	suggests	that	there	is	a	delay	between	one	and	two	weeks	between	influenza	incidence	and	associated	mortality.	For	the	purposes	of	relating	influenza	incidence	to	mortality	we	considered	influenza	incidence	proxies	shifted	forward	by	either	1	or	2	weeks,	with	the	shifted	monthly	incidence	proxies	derived	from	the	shifted	weekly	incidence	proxies	in	a	manner	described	in	the	preceding	paragraph.	For	example,	the	incidence	proxy	for	a	given	month	shifted	by	2	weeks	is	the	weighted	average	of	the	weekly	incidence	proxies	for	those	weeks	whose	2-week	forward	shift	overlaps	with	a	given	month.	The	choice	of	shifting	the	influenza	incidence	proxies	by	1	week	or	2	weeks	in	fitting	the	mortality	data	is	determined	by	the	Akaike	Information	Criterion	(AIC)	scores	similarly	to	other	choices	of	parameters	described	below.		If	𝑀(𝑡)	is	the	mortality	rate	for	a	given	cause	on	month	𝑡 	(with	𝑡 = 1	for	09/2010),	and	𝐴/𝐻3𝑁2(𝑡),𝐴/𝐻1𝑁1! (𝑡),𝐴/𝐻1𝑁1! (𝑡),𝐵(𝑡)	are	the	shifted	incidence	proxies	for	the	major	influenza	(sub)types	on	month	𝑡	,	then	the	inference	model	in	[2,3]	suggests	that					𝑀 𝑡 = 𝛽! + 𝛽! ∙ 𝐴/𝐻3𝑁2(𝑡)+ 𝛽! ∙ 𝐴/𝐻1𝑁1! (𝑡)+ 𝛽! ∙ 𝐴/𝐻1𝑁1! (𝑡)+ 𝛽! ∙  𝐵(𝑡)+𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒 + 𝑇𝑟𝑒𝑛𝑑 ++ 𝑁𝑜𝑖𝑠𝑒																											(2)	
	
Here	𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒	is	the	baseline	rate	of	mortality	not	associated	with	influenza	circulation	that	is	periodic	with	yearly	periodicity.	To	accommodate	the	baseline’s	unknown	shape,	we	will	model	it	as		 𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑡 = 𝛽! ∙ cos 2𝜋𝑡12 + 𝛽! ∙ sin 2𝜋𝑡12  + 𝛽! ∙ cos 2𝜋𝑡6 + 𝛽!∙ sin 2𝜋𝑡6  + 𝛽! ∙ 𝐽𝑎𝑛		Here	𝐽𝑎𝑛	is	a	variable	equaling	1	for	the	month	of	January,	0	otherwise	(see	Supporting	Information).	The	reason	for	including	this	variable	is	that	data	suggest	bumps	in	mortality	in	January,	even	under	low	influenza	circulation/	ILI/ARI	rates	(particularly	for	the	2012/13	season).	Such	bumps	(also	seen	for	the	2007/08	season	under	low	influenza	circulation)	are	likely	explained	by	cold	weather	[6]	(with	the	January	effect	on	circulatory	mortality	in	Russia	examined	in	[18]),	and	possibly	by	the	circulation	of	other	respiratory	viruses.	The	(temporal)	trend	is	modeled	as	a	low	degree	polynomial	in	time,	or	time	periods,	as	explained	below,	with	explicit	model	equations	for	respiratory	mortality,	circulatory	mortality	and	mortality	for	certain	infectious	and	parasitic	diseases	presented	further	down	in	this	section.		The	Akaike	Information	Criterion	(AIC)	is	adopted	to	select	the	variables	(covariates)	in	the	model	for	each	mortality	cause,	with	the	variable	whose	omission	results	in	the	largest	decline	in	the	AIC	score	being	dropped	at	each	step	until	no	omissions	of	a	variable	decrease	the	AIC	score.	The	model	equations	for	respiratory	mortality,	circulatory	mortality	and	mortality	due	to	certain	infectious	and	parasitic	diseases	are	as	follows:		
Respiratory	mortality.	While	there	is	no	obvious	long-term	trend	in	respiratory	mortality	in	Figure	2,	clearly	there	are	seasonal	fluctuations	not	related	to	influenza	circulation,	and	those	are	likely	related	to	the	circulation	of	other	respiratory	viruses.	We	will	accommodate	those	seasonal	effects	by	modeling	the	temporal	trend	as	a	function	of	a	
season,	where	the	season	for	the	circulation	of	other	respiratory	viruses	is	modeled	to	run	from	July	to	June.	Let	𝑇𝑠1	be	a	linear	function	of	the	season	(equaling	1	for	the	months	of	09/2010	through	06/2011,	to	2	for	07/2011	through	06/2012	etc.),	𝑇𝑠2 = 𝑇𝑠1!,	𝑇𝑠3 = 𝑇𝑠1!,	etc.	are	the	powers	in	𝑇𝑠1.		Then	the	model	equation	for	respiratory	mortality	selected	using	the	AIC	criterion	is:			𝑀!"#$ 𝑡 = 𝛽! + 𝛽! ∙ 𝐴/𝐻3𝑁2(𝑡)+ 𝛽! ∙ 𝐴/𝐻1𝑁1! 𝑡 + 𝛽! ∙ 𝐴/𝐻1𝑁1! 𝑡 + 𝛽! ∙  𝐵 𝑡 + 𝛽! ∙ sin !!"!" + 𝛽! ∙ cos !!"! + 𝛽! ∙ 𝑇𝑠2+ 𝛽! ∙ 𝑇𝑠3+ 𝛽! ∙ 𝑇𝑠4+ 𝛽!" ∙ 𝐽𝑎𝑛      (3)			We	note	that	all	the	variables	in	the	linear	regression	equation	(3)	are	essential	in	the	sense	that	removing	each	of	them	increases	the	AIC	score	of	the	model.		
Circulatory	mortality	and	mortality	due	to	certain	infectious	and	parasitic	diseases.	Figure	2	suggests	that	there	is	a	continuous	downward	trend	in	those	two	mortality	time	series.	Therefor,	we	model	the	trend	as	a	low	degree	polynomial	in	the	month	𝑡,	not	the	season	(with	that	choice	justified	not	only	by	the	visual	inspection	of	Figure	2	but	also	by	the	AIC	criterion).	The	model	equations	selected	by	the	AIC	criterion	are:					Circulatory	deaths:		𝑀!"#! 𝑡 = 𝛽! + 𝛽! ∙ 𝐵 𝑡 + 𝛽! ∙ cos !!"!" + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝐽𝑎𝑛				(4)																		Infectious	and	Parasitic	disease	deaths:			𝑀!" 𝑡 = 𝛽! +	𝛽! ∙ 𝐴/𝐻1𝑁1! 𝑡 + 𝛽! ∙ 𝐵 𝑡 +𝛽! ∙ cos !!"!" + 𝛽! ∙ sin !!"!" + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡!																																					(5)																																		We	note	that	a	number	of	terms	for	the	different	influenza	(sub)types	are	omitted	by	the	AIC	criterion	for	the	mortality	causes	in	eqns.	(4,5).	Compared	to	respiratory	mortality,	those	omissions	might	be	related	to	the	fact	that	the	relative	effect	of	influenza	circulation	on	mortality	is	higher	for	respiratory	deaths	compared	to	the	other	categories	of	deaths;	correspondingly,	the	effects	of	circulation	of	each	influenza	
(sub)type	on	the	monthly	mortality	are	mixed	with	the	relatively	larger	fluctuations	in	the	monthly	mortality	counts	for	non-respiratory	categories	compared	to	the	respiratory	categories,	resulting	in	potential	lack	of	ascertainability	as	expressed	by	the	(lack	of)	justification	of	including	those	covariates	via	the	AIC	score.	We	also	note	in	that	regard	that	it	is	visually	clear	that	for	example	the	incidence	proxy	for	influenza	A/H3N2	was	growing	towards	its	peak	when	circulatory	mortality	was	declining	for	three	out	of	five	seasons	in	the	data,	which	may	help	explain	its	exclusion	from	the	corresponding	model.	Given	the	high	correlation	between	the	incidence	proxies	for	the	different	influenza	(sub)types,	omitting	one	(sub)type	from	the	regression	model	affects	the	regression	coefficients	for	the	other	(sub)types.	Thus	models	given	by	eqns.	(4,5)	are	meant	to	estimate	the	contribution	of	all	influenza	(sub)types,	not	only	the	ones	included	to	the	corresponding	mortality	rates,	though	only	as	the	average	over	the	study	period	(with	annual	estimates	being	less	certain)	–	see	also	the	Discussion	regarding	the	contribution	of	influenza	A	to	circulatory	mortality	in	Russia.		
	
	
Results	
	Figure	1	plots	the	monthly	incidence	proxies	for	influenza	A/H1N1,	A/H3N2	and	B	in	Russia	between	09/2010	and	12/2015.	Figure	2	plots	the	monthly	rates	of	respiratory	deaths,	circulatory	deaths,	and	deaths	for	certain	infectious	and	parasitic	diseases	between	09/2010	and	12/2015.	One	sees	that	during	seasons	of	high	influenza	circulation	(particularly	the	2014/15	season	that	had	the	highest	circulation	of	influenza	B	and	A/H3N2,	Figure	1),	the	peak	periods	of	each	of	the	three	mortality	times	series	in	Figure	2	were	largest;	for	the	relatively	smaller	influenza	seasons	(2011/12	and	2013/14),	peaks	of	the	corresponding	mortality	time	series	were	relatively	smaller.		
	
	
	
Figure1:	Monthly	incidence	proxies	for	influenza	A/H3N2,	A/H1N1	and	B	in	Russia,	9/2010	through	12/2015.		
	
	
Figure	2:	Rates	of	daily	mortality	for	respiratory	causes	(per	one	million	individuals	in	Russia),	circulatory	causes	(per	100,000	individuals),	and	for	certain	infectious	and	parasitic	diseases	(per	one	million	individuals)	by	month,	9/2010	through	12/2015.		
Respiratory	deaths.	Figure	3	plots	the	fits	for	the	model	for	respiratory	mortality	given	by	eq.	(3).	The	fits	appear	to	be	fairly	temporally	consistent,	with	the	weekly	contribution	of	influenza	to	mortality	estimated	as	the	difference	between	the	red	and	the	green	curves	in	Figure	3.		
	
	
Figure	3:	Model	fit	for	the	daily	rates	of	respiratory	deaths	per	100,000	by	month	in	Russia,	9/2010	though	12/2105.	The	contribution	of	influenza	to	respiratory	mortality	is	represented	by	the	difference	between	the	red	and	the	green	curves.		Table	1	presents	the	estimates	of	the	contribution	of	influenza	A/H3N2,	A/H1N1,	influenza	B	and	all	of	influenza	to	respiratory	mortality	for	each	of	the	2010/11	through	the	2014/15	seasons	(with	each	influenza	season	assumed	to	run	from	September	through	June),	as	well	as	the	annual	averages	for	the	corresponding	contributions	for	the	2010/11	through	the	2014/15	time	period	(5	seasons),	with	the	nascent	2015/2016	influenza	epidemic	between	09/2015	and	12/2015	excluded	from	the	latter	estimates	(though	data	for	the	09/2015	through	the	12/15	period	is	included	in	the	regression	model).	We	estimate	an	annual	average	of	4552(3744,5360)	influenza-associated	
respiratory	deaths	during	the	study	period,	with	over	a	half	of	those	deaths	being	due	to	influenza	A/H3N2.	The	2014/15	season	had	the	largest	number	of	estimated	influenza-associated	deaths:	6128(4734,7521).		Season	/Flu	type	 A/H3N2	 A/H1N1	 Influenza	B	 All	influenza	2010-11	 837(438,1237)	 2304(570,4039)	 1687(73,3300)	 4828(3419,6237)	2010-12	 2722(1423,4021)	 61(5.1,116)	 445(19,872)	 3228(2198,4258)	2012-13	 2286(1195,3377)	 1554(131,2976)	 1287(56,2517)	 5126(3781,6471)	2013-14	 2402(1255,3549)	 554(47,1062)	 495(21,969)	 3451(2621,4281)	2014-15	 3807(1990,5624)	 279(24,535)	 2042(88,3995)	 6128(4734,7521)	Annual	average	 2411(1260,3561)	 950	(374,1527)	 1191(52,2331)	 4552(3744,5360)		
Table	1:	Seasonal	and	average	annual	number	of	respiratory	deaths	associated	with	the	different	influenza	(sub)types,	as	well	as	with	influenza	overall	for	the	2010-11	through	the	2014-15	seasons	in	Russia.		
Circulatory	deaths	and	deaths	due	to	certain	infectious	and	parasitic	diseases.	Table	2	presents	the	estimates	of	the	average	annual	numbers	of	circulatory	deaths,	as	well	as	deaths	due	to	certain	infectious	and	parasitic	diseases	associated	with	influenza	circulation	for	the	2010/11	through	the	2014/15	seasons.	We	estimate	an	annual	average	of	11106	(4321,17892)	influenza-associated	circulatory	deaths,	and	an	annual	average	of	343	(63,624)	influenza-associated	deaths	due	to	certain	infectious	and	parasitic	diseases.	We	note	that	the	estimated	ratio	of	circulatory	to	respiratory	influenza-associated	deaths	in	Russia	(about	2.44-to-1	Table	2	vs.	Table	1)	is	quite	higher	that	the	corresponding	estimate	(about	1.35-to-1,	[2])	for	the	US.	At	the	same	time,	the	overall	ratio	of	circulatory-to-respiratory	deaths	in	Russia	(about	14-to-1	in	2018,	[12])	is	much	higher	than	the	corresponding	ratio	in	the	US	(about	3.08-to-1	in	2017,	[19]).	
	Cause	 Annual	average	number	of	deaths	Circulatory	deaths	 11106	(4321,17892)	Deaths	for	certain	infectious	and	parasitic	diseases	 343	(63,624)		
Table	2:	Average	annual	number	of	influenza-associated	deaths	for	circulatory	causes	and	for	certain	infectious	and	parasitic	diseases	for	the	2010-11	through	the	2014-15	seasons	in	Russia.		Figures	4,5	plot	the	model	fits	for	the	rates	of	circulatory	deaths,	as	well	as	deaths	due	to	certain	infectious	and	parasitic	diseases.	The	model	fit	for	circulatory	deaths	is	less	consistent	than	for	respiratory	deaths	(Figure	4	vs.	3).	For	example,	the	major	circulatory	mortality	peak	during	the	2012/13	season	is	not	well-explained	by	the	model	in	eq.	(4).	At	the	same	time,	this	peak	might	indeed	largely	be	not	influenza-associated	as	it	preceded	the	period	of	high	influenza	circulation	as	described	by	the	incidence	proxies	in	Figure	1,	and	this	also	applies	to	an	extent	for	the	2011/12	season	–	see	also	the	2nd	paragraph	of	the	Discussion.			
	
	
Figure	4:	Model	fit	for	the	daily	rates	of	circulatory	deaths	per	100,000	by	month	in	Russia,	9/2010	though	12/2105.	The	contribution	of	influenza	to	circulatory	mortality	is	represented	by	the	difference	between	the	red	and	the	green	curves.				
	
	
Figure	5:	Model	fit	for	the	daily	rates	of	deaths	for	certain	infectious	and	parasitic	diseases	per	100,000	by	month	in	Russia,	9/2010	though	12/2105.	The	contribution	of	influenza	to	mortality	for	certain	infectious	and	parasitic	diseases	is	represented	by	the	difference	between	the	red	and	the	green	curves.			
Discussion	
	Influenza	circulation	is	known	to	be	associated	with	substantial	mortality	burden	in	the	Northern	Hemisphere,	e.g.	[2-7].	At	the	same	time,	there	is	limited	information	on	the	volume	of	influenza-related	mortality	in	Russia,	though	some	regional	estimates,	particularly	for	the	city	of	St.	Petersburg	are	available	[9].	In	this	paper,	we	applied	the	previously	developed	methodology	that	was	used	to	evaluate	the	rates	of	influenza-associated	mortality	in	several	countries,	e.g.	[2,3,5-7]	to	estimate	the	rates	of	influenza-
associated	mortality	for	three	causes	of	death	(respiratory	causes,	circulatory	causes,	and	certain	infectious	and	parasitic	diseases)	for	the	period	between	the	2010/11	through	the	2014/15	influenza	seasons	in	Russia.	We	estimate	about	16,001	annual	influenza-associated	deaths	for	those	three	causes	during	that	period,	the	majority	of	which	(about	11,106)	are	for	circulatory	causes,	with	influenza	A/H3N2	being	responsible	for	the	majority	of	influenza-associated	respiratory	deaths	and	influenza	B	playing	a	substantial	role	in	the	influenza-associated	circulatory	mortality	(see	also	[13]).	The	prominence	of	circulatory	deaths	among	influenza-associated	mortality	may	be	related	to	the	overall	high	rates	of	circulatory	deaths	in	Russia	[12].	We	hope	that	this	work	may	help	inform	mitigation	efforts.	In	particular,	the	role	played	by	influenza	B	in	the	circulatory	mortality	burden	supports	the	potential	benefit	of	quadrivalent	influenza	vaccines	(with	trivalent	influenza	vaccines	not	containing	the	influenza	B/Yamagata	strains	that	can	be	a	source	of	high	levels	of	excess	mortality	[10]).	We	also	note	in	that	regard	that	the	2018/19	influenza	season	saw	minimal	circulation	of	influenza	B	in	Russia	[15],	raising	the	possibility	of	a	major	influenza	B	epidemic	during	the	2019/20	season,	which	further	suppors	the	need	for	a	quadrivalent	influenza	vaccine,	particularly	for	individuals	with	cardiac	disease.	Additionally,	administration	of	antiviral	medications	for	certain	population	subgroups	defined	by	age	and	presence	of	underlying	health	conditions	(particularly	circulatory	diseases)	may	help	mitigate	the	burden	of	severe	outcomes	during	influenza	epidemics	in	Russia.		Our	study	has	some	limitations.	We	only	had	access	to	monthly	mortality	data,	with	the	signal	of	influenza	circulation	in	those	data	being	mixed	with	other	fluctuations	of	relatively	high	magnitude,	particularly	for	non-respiratory	causes.	While	the	model	fits	for	respiratory	causes	exhibited	a	good	deal	of	temporal	consistency,	this	wasn’t	the	case	for	circulatory	causes	during	certain	seasons,	particularly	the	2012/13	season.	While	earlier	work,	e.g.	[13],	as	well	as	Table	3	in	[2]	(comparison	of	regression	coefficients	for	circulatory	vs.	respiratory	deaths)	also	supports	the	important	role	played	by	influenza	B	in	circulatory	influenza-associated	mortality,	there	is	uncertainty	regarding	our	estimates	of	the	contribution	of	influenza	A	to	circulatory	mortality.	It	might	be	that	our	model	had	missed	some	of	the	contribution	of	influenza,	particularly	influenza	A	to	
mortality,	especially	circulatory	mortality,	with	the	circulatory	mortality	peaks	during	the	2012/13	season	potentially	being	related	to	influenza	A	infections	contrary	to	the	model’s	results	(Figure	4).	At	the	same	time,	other	factors	might	have	affected	this	peak	in	circulatory	mortality.	Indeed,	for	the	2012/13	season,	the	peak	of	circulatory	mortality	preceded	the	peak	periods	of	both	influenza	circulation	and	ILI/ARI	rates.	Moreover,	the	peak	of	respiratory	mortality	was	broader	than	the	peak	of	circulatory	mortality	during	that	season	(Figure	2),	with	the	later	part	of	that	peak	in	respiratory	mortality	explained	well	by	influenza	circulation	(Figure	3),	and	the	earlier	part,	matching	temporally	the	peak	in	circulatory	mortality	(Figure	2),	not	being	explained	by	influenza	circulation	(Figure	3).	It	may	be	that	cold	weather	[6],	and	possibly	the	circulation	of	other	respiratory	viruses	have	affected	both	the	respiratory	and	circulatory	mortality	during	the	2012/13	season.	We	also	note	the	major	peak	in	both	circulatory	and	respiratory	mortality	in	January,	2008	that	couldn’t	be	explained	by	influenza	circulation	(Figures	1	and	4	in	[1]).	Further	work	involving	more	granular	data,	including	climatic	data	[18],	weekly	mortality	data,	as	well	as	data	stratified	by	age	is	needed	to	better	understand	“excess	mortality”	and	the	contribution	of	influenza	to	the	mortality	rates	in	Russia,	particularly	the	contribution	of	influenza	A	to	circulatory	mortality.		We	believe	that	despite	those	limitations,	this	work	provides	a	national	study	of	influenza-related	mortality	in	Russia,	giving	evidence	for	the	substantial	burden	of	influenza-associated	mortality,	particularly	for	circulatory	causes,	and	the	contribution	of	influenza	B	to	the	volume	of	influenza-associated	mortality.	We	hope	that	this	work	would	stimulate	further	efforts	involving	more	granular	data	(in	particular,	weekly	mortality	data,	as	well	as	data	stratified	by	age)	to	better	understand	the	effect	of	influenza	epidemics	in	Russia	on	mortality	and	help	inform	mitigation	efforts	for	certain	population	subgroups.			
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Supporting	Information	for:	Influenza-associated	mortality	for	different	causes	of	
death	during	the	2010-2011	through	the	2014-2015	influenza	seasons	in	Russia	
	Here,	we	examine	the	results	of	the	inference	model	when	the	variable	for	the	January	effect	of	mortality	is	not	included.	Below	are	the	equations	for	the	models	(selected	by	the	AIC	criterion)	for	respiratory	mortality,	circulatory	mortality,	and	mortality	for	certain	infectious	and	parasitic	diseases	(compare	with	eqns.	3-5):			Respiratory:	𝑀!"#$ 𝑡 = 𝛽! + 𝛽! ∙ 𝐴/𝐻3𝑁2(𝑡)  + 𝛽! ∙ 𝐴/𝐻1𝑁1!(𝑡)  + 𝛽! ∙ 𝐴/𝐻1𝑁1!(𝑡)  +𝛽! ∙  𝐵(𝑡)+  𝛽! ∙ cos (!!"!" )+ 𝛽! ∙ sin (!!"!" )+ 𝛽! ∙ 𝑇𝑠2+ 𝛽! ∙ 𝑇𝑠3+ 𝛽! ∙ 𝑇𝑠4        (𝑆1)		Circulatory:			𝑀!"#! 𝑡 = 𝛽! + 𝛽! ∙ 𝐵 𝑡 + 𝛽! ∙ cos !!"!" + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡!				(S2)																		Infectious	and	Parasitic	diseases:		𝑀!" 𝑡 = 𝛽! +	𝛽! ∙ 𝐴/𝐻1𝑁1! 𝑡 + 𝛽! ∙ 𝐵 𝑡 + 𝛽! ∙cos !!"!" + 𝛽! ∙ sin !!"!" + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡! + 𝛽! ∙ 𝑡!																																					(S3)																																		Table	S1	summarizes	the	comparison	for	the	models	with	and	without	the	January	effect	in	terms	of	the	AIC	score,	R-squared	statistic,	and	estimated	average	annual	numbers	of	influenza-associated	deaths.	One	sees	significant	improvement	in	the	model	fits	for	respiratory	and	circulatory	deaths	with	the	inclusion	of	the	January	effect	–	see	also	[S1].			 Model	with	January	effect	 	 Model	without	January	effect		 AIC	score	 R-squared	 Average	annual	mortality	 	 AIC	score	 R-squared	 Average	annual	mortality	Respiratory	 -422.28	 0.795	 4552	(3744,5360)	 	 -416.76	 0.769	 3659	(2475,4843)	Circulatory	 -143.06	 0.854	 11106	(4321,17892)	 	 -136.76	 0.833	 9558	(2280,16836)	Certain	infectious	parasitic	diseases	
-561.26	 0.563	 343	(63,624)	 	 -561.26	 0.563	 343	(63,624)	
	Table	S1:	Comparison	of	the	models	with	and	without	the	January	effect	on	mortality.			
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